Synchron

Will the BCI Market Thrive Before Elon Musk's Neuralink?

IDTechEx outlines the competition Neuralink is facing from not only other invasive brain computer interface developers, but also from the more established eco-system of non-invasive solution providers.

uCat

uCat is a new company seeking to fill a gap in the market for a tool which optimizes the training experience for brain-computer interface users.

Feasibility Trials for First Interventional Neuromodulation Platform

The study is the first clinical trial to evaluate the safety and efficacy of the Stentrode, the first interventional neuromodulation platform. This technology is designed to translate brain activity from the inside of a blood vessel, and is being explored for its potential to enable hands-free control of devices for people with upper limb paralysis.

Stimulating the brain without major surgery

A team of researchers have been working on a replacement for open brain surgery since 2012, inventing a stimulation device that can be implanted in blood vessels next to the brain's motor cortex, in a minimally invasive procedure involving a small 'keyhole' incision in the neck.